FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The FDA is reviewing Moderna's mRNA-based influenza vaccine for potential approval. A decision on the vaccine candidate is expected in the coming months. Moderna has not yet disclosed a specific timeline for the FDA's determination.

Next story